* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected
to show a
rise in quarterly revenue when it reports results on October
27.
* The Burlington Massachusetts-based company is expected to
report a 4.4% increase in revenue to $40.06 million from $38.37
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
July 28 2022, for the period ended September 30, was for revenue
between $39.00 million and $41.00 million.
* Refinitiv's mean analyst estimate for LeMaitre Vascular
Inc is
for earnings of 28 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular
Inc is $56, above its last closing price of $51.87.
The company's guidance on July 28 2022 for the period ended
September 30 was for Earnings before Interest and Taxes between
USD6.8 million and USD8.2 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.27 0.27 0.16 Missed -39.6
Mar. 31 2022 0.28 0.28 0.27 Missed -2.6
Dec. 31 2021 0.31 0.31 0.28 Missed -8.6
Sep. 30 2021 0.33 0.33 0.30 Missed -7.7
Jun. 0.35 0.34 0.40 Beat 18.2
30 2021
Mar. 31 2021 0.27 0.27 0.28 Beat 3.1
Dec. 31 2020 0.30 0.29 0.34 Beat 15.9
Sep. 30 2020 0.20 0.19 0.37 Beat 90.7
This summary was machine generated October 26 at 02:01 GMT. All
figures in US dollars unless otherwise stated